共 50 条
DNA-Encoded Library Screening To Inform Design of a Ribonuclease Targeting Chimera (RiboTAC)
被引:28
|作者:
Meyer, Samantha M.
[1
,2
]
Tanaka, Toru
[1
,2
]
Zanon, Patrick R. A.
[1
,2
]
Baisden, Jared T.
[1
,2
]
Abegg, Daniel
[1
,2
]
Yang, Xueyi
[1
,2
]
Akahori, Yoshihiro
[1
,2
]
Alshakarchi, Zainab
[1
,2
]
Cameron, Michael D.
[1
,2
]
Adibekian, Alexander
[1
,2
]
Disney, Matthew D.
[1
,2
]
机构:
[1] UF Scripps Biomed Res, Dept Chem, Jupiter, FL 33458 USA
[2] Scripps Res Inst, Jupiter, FL 33458 USA
基金:
美国国家卫生研究院;
关键词:
BIOACTIVE SMALL MOLECULES;
RNASE-L;
TAR-RNA;
MECHANISM;
PRECURSOR;
MIR-21;
D O I:
10.1021/jacs.2c07217
中图分类号:
O6 [化学];
学科分类号:
0703 ;
摘要:
Ribonuclease targeting chimeras (RiboTACs) induce degradation of an RNA target by facilitating an interaction between an RNA and a ribonuclease (RNase). We describe the screening of a DNA-encoded library (DEL) to identify binders of monomeric RNase L to provide a compound that induced dimerization of RNase L, activating its ribonuclease activity. This compound was incorporated into the design of a next-generation RiboTAC that targeted the microRNA-21 (miR-21) precursor and alleviated a miR-21-associated cellular phenotype in triple-negative breast cancer cells. The RNA-binding module in the RiboTAC is Dovitinib, a known receptor tyrosine kinase (RTK) inhibitor, which was previously identified to bind miR-21 as an off-target. Conversion of Dovitinib into this RiboTAC reprograms the known drug to selectively affect the RNA target. This work demonstrates that DEL can be used to identify compounds that bind and recruit proteins with effector functions in heterobifunctional compounds.
引用
收藏
页码:21096 / 21102
页数:7
相关论文